- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it https://atelfo.github.io/2023/12/23/biopharma-from-janssen-to-today.html 5 comments truereddit
Linking pages
- We Need Major, But Not Radical, FDA Reform https://www.maximum-progress.com/p/we-need-major-but-not-radical-fda 5 comments
- But does surgery really work well without the FDA? https://atelfo.substack.com/p/but-does-surgery-really-work-well 1 comment
- The dead and dying at the gates of oncology clinical trials « The Story's Story https://jakeseliger.com/2024/01/29/the-dead-and-dying-at-the-gates-of-oncology-clinical-trials/ 0 comments
- Some questions about biotech that I find interesting | Alex’s blog https://atelfo.github.io/2024/04/01/biotech-questions.html 0 comments
Linked pages
- AlphaFold reveals the structure of the protein universe https://www.deepmind.com/blog/alphafold-reveals-the-structure-of-the-protein-universe 236 comments
- The rise and fall of the industrial R&D lab - Works in Progress https://www.worksinprogress.co/issue/the-rise-and-fall-of-the-american-rd-lab/ 169 comments
- Use Only as Directed — ProPublica http://www.propublica.org/article/tylenol-mcneil-fda-use-only-as-directed 45 comments
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy | NEJM http://www.nejm.org/doi/full/10.1056/nejmoa1706198 26 comments
- Cancer - Our World in Data https://ourworldindata.org/cancer 24 comments
- Tuskegee Syphilis Study - Wikipedia https://en.wikipedia.org/wiki/Tuskegee_Syphilis_Study 6 comments
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy | NEJM http://www.nejm.org/doi/full/10.1056/nejmoa1702752 3 comments
- 2022 FDA approvals https://www.nature.com/articles/d41573-023-00001-3 3 comments
- Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2117175 2 comments
- Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2113708 1 comment
- Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals | FDA https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-janssen-covid-19-vaccine-certain-individuals 1 comment
- Decade-long leukaemia remissions with persistence of CD4+ CAR T cells | Nature https://www.nature.com/articles/s41586-021-04390-6#Abs1 1 comment
- Chemical space - Wikipedia https://en.wikipedia.org/wiki/Chemical_space 0 comments
- The lightning-fast quest for COVID vaccines — and what it means for other diseases https://www.nature.com/articles/d41586-020-03626-1 0 comments
- Cytokine storm - Wikipedia https://en.wikipedia.org/wiki/Cytokine_storm 0 comments
- Breaking Eroom’s Law https://www.nature.com/articles/d41573-020-00059-3 0 comments
- Vaccination - Our World in Data https://ourworldindata.org/vaccination 0 comments
- Jesse Gelsinger - Wikipedia https://en.wikipedia.org/wiki/Jesse_Gelsinger 0 comments
- The Magic of Randomization versus the Myth of Real-World Evidence | NEJM https://www.nejm.org/doi/full/10.1056/NEJMsb1901642 0 comments
- https://www.science.org/content/blog-post/protein-design-ai-way 0 comments
Related searches:
Search whole site: site:atelfo.github.io
Search title: The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blog
See how to search.